Vault-13

Polaris Venture Management Co. V, L.L.C.

Boston, MA · CIK 1439589 · 13F filing filed 2021-11-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$14.1m reported value -77.4% vs Q2 2021
6positions
100.0%in top 10
0 new 0 added 0 reduced 1 sold out vs Q2 2021

Holdings, Q3 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 LYRA THERAPEUTICS INC COM LYRA LYRA 1,100,852 $10.0m71.28% 71.28% UnchangedShares held: Q4 2020 1.1m, Q1 2021 1.1m, Q2 2021 1.1m, Q3 2021 1.1m
2 X4 PHARMACEUTICALS INC COM COM 311,492 $1.6m11.70% 11.70% UnchangedShares held: Q4 2020 311.5k, Q1 2021 311.5k, Q2 2021 311.5k, Q3 2021 311.5k
3 ATYR PHARMA INC COM LIFE LIFE 130,572 $1.2m8.42% 8.42% UnchangedShares held: Q4 2020 130.6k, Q1 2021 130.6k, Q2 2021 130.6k, Q3 2021 130.6k
4 DARE BIOSCIENCE INC COM COM 326,240 $545.0k3.87% 3.87% UnchangedShares held: Q4 2020 326.2k, Q1 2021 326.2k, Q2 2021 326.2k, Q3 2021 326.2k
5 GENOCEA BIOSCIENCES INC COM NEW GNCAQ GNCAQ 197,345 $379.0k2.69% 2.69% UnchangedShares held: Q4 2020 197.3k, Q1 2021 197.3k, Q2 2021 197.3k, Q3 2021 197.3k
6 PULMATRIX INC COM NEW PULM PULM 359,441 $288.0k2.04% 2.04% UnchangedShares held: Q4 2020 359.4k, Q1 2021 359.4k, Q2 2021 359.4k, Q3 2021 359.4k

Sold out since Q2 2021

SecurityTickerShares held beforeValue then
FATE THERAPEUTICS INC FATE FATE 569,889 $49.5m569.9k shares